Could Popular Weight-Loss Medications Affect Your Eyes?

You may have heard of medications like Ozempic®, Wegovy®, Mounjaro®, and Zepbound® — they’re part of a growing group of drugs called GLP-1 receptor agonists (GLP-1RAs). These medications have become very popular for managing type 2 diabetes and helping with weight loss. While these medications can offer major health benefits, new research from the American Optometric Association (AOA) suggests there may be some eye-related risks that patients and eye doctors should keep an eye on — especially for people who already have diabetes or other eye conditions.

What Are GLP-1 Medications?

GLP-1 medications work by mimicking a natural hormone in the body that helps lower blood sugar, reduce appetite, and slow digestion. Many patients see great results with them — including better blood sugar control and healthy weight loss.

Common examples include semaglutide (Ozempic®, Wegovy®) and tirzepatide (Mounjaro®, Zepbound®). Because they’re so effective, millions of people in the U.S. are now taking one of these medications.

Why Eye Health Matters

Most people using these medications won’t experience any eye problems. But for a small number of patients, changes in the eyes have been reported. These include:

Diabetic Retinopathy (DR) Changes – Some studies found that diabetic patients who started semaglutide had a slightly higher chance of worsening eye bleeding or swelling during the first year of treatment. This doesn’t mean the drug caused the problem directly — rapid blood sugar changes can sometimes trigger shifts in diabetic eye disease.
Optic Nerve Changes (NAION) – A rare condition called non-arteritic anterior ischemic optic neuropathy (NAION) has been reported in a small number of people taking these medications. It usually causes sudden, painless vision loss in one eye. The risk is still considered very low, but it’s something your eye doctor will watch for.
Age-Related Macular Degeneration (AMD) – A few studies suggest people with diabetes on GLP-1 medications might have a slightly higher chance of developing the “wet” form of macular degeneration. Again, this risk appears small — but worth monitoring if you’re already at risk.

What You Can Do

If you’re taking or starting a GLP-1 medication, here are a few ways to protect your eyes:

Schedule a baseline eye exam. Get a full, dilated eye exam before (or soon after) starting your medication. This gives your optometrist a clear picture of your current eye health.

Follow up regularly. If you have diabetes, macular degeneration, or other eye concerns, your doctor may recommend more frequent visits during your first year on the medication.

Report any sudden vision changes right away. If you notice blurred vision, dim spots, or sudden loss of sight in one eye, don’t wait — call your eye doctor immediately.

Keep your doctors in the loop. Make sure your primary care provider and your optometrist are aware of all the medications you’re taking, including GLP-1s.

The Bottom Line

GLP-1 medications remain safe and effective for most patients, and the potential eye effects are rare. The key is awareness and regular eye care. If you’ve recently started Ozempic®, Wegovy®, Mounjaro®, or a similar medication, this is a great time to schedule a comprehensive eye exam. Early detection is the best protection when it comes to your vision.

Sources